2024-10-01 2025-09-30 false Capium Accounts Production 1.1 14376321 2024-10-01 2025-09-30 14376321 bus:FullAccounts 2024-10-01 2025-09-30 14376321 bus:FRS102 2024-10-01 2025-09-30 14376321 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 14376321 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 14376321 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 14376321 2024-10-01 2025-09-30 14376321 2025-09-30 14376321 bus:RegisteredOffice 2024-10-01 2025-09-30 14376321 core:WithinOneYear 2025-09-30 14376321 core:AfterOneYear 2025-09-30 14376321 1 2024-10-01 2025-09-30 14376321 bus:Director1 2024-10-01 2025-09-30 14376321 bus:Director1 2025-09-30 14376321 bus:Director1 2023-10-01 2024-09-30 14376321 2023-10-01 14376321 bus:LeadAgentIfApplicable 2024-10-01 2025-09-30 14376321 2023-10-01 2024-09-30 14376321 2024-09-30 14376321 core:WithinOneYear 2024-09-30 14376321 core:AfterOneYear 2024-09-30 14376321 bus:EntityAccountantsOrAuditors 2023-10-01 2024-09-30 14376321 core:PlantMachinery 2024-10-01 2025-09-30 14376321 core:PlantMachinery 2025-09-30 14376321 core:PlantMachinery 2024-09-30 14376321 core:ComputerEquipment 2024-10-01 2025-09-30 14376321 core:ComputerEquipment 2025-09-30 14376321 core:ComputerEquipment 2024-09-30 14376321 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-09-30 14376321 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-09-30 14376321 core:CostValuation core:Non-currentFinancialInstruments 2025-09-30 14376321 core:CostValuation core:Non-currentFinancialInstruments 2024-09-30 14376321 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-09-30 14376321 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 14376321 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 14376321 core:Non-currentFinancialInstruments 2025-09-30 14376321 core:Non-currentFinancialInstruments 2024-09-30 14376321 core:RetainedEarningsAccumulatedLosses 2025-09-30 14376321 core:RetainedEarningsAccumulatedLosses 2024-09-30 14376321 dpl:Item1 2024-10-01 14376321 dpl:Item1 2025-09-30 14376321 dpl:Item1 2023-10-01 14376321 dpl:Item1 2024-09-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 14376321
England and Wales

 

 

 

BIOSURV INTERNATIONAL LTD



Unaudited Financial Statements
 


Period of accounts

Start date: 01 October 2024

End date: 30 September 2025
Director C B Pratt
Registered Number 14376321
Registered Office The Lyle Building Porton Science Park
Clewer Road, Porton Down
Salisbury
Wiltshire
SP4 0DQ
Accountants Numeric Accounting Limited
Suite 1, The Portway Centre
1 Old Sarum Park, Old Sarum
Salisbury
SP4 6EB
1
 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Tangible fixed assets 3 73,916    21,312 
73,916    21,312 
Current assets      
Debtors 4 26,123    8,525 
Cash at bank and in hand 642,498    387,259 
668,621    395,784 
Creditors: amount falling due within one year 5 (249,151)   (149,207)
Net current assets 419,470    246,577 
 
Total assets less current liabilities 493,386    267,889 
Net assets 493,386    267,889 
 

Capital and reserves
     
Other Reserves 493,386    267,889 
Members' funds 493,386    267,889 
 


For the year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 19 June 2026 and were signed by:


-------------------------------
C B Pratt
Director
2
General Information
Biosurv International Ltd is a private company, limited by guarantee, registered in England and Wales, registration number 14376321, registration address The Lyle Building Porton Science Park, Clewer Road, Porton Down, Salisbury, Wiltshire, SP4 0DQ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Grants
Grants received are credited to deferred income. Grants towards capital expenditure are released to the income statement over the expected useful life of the assets. Grants received towards revenue expenditure are released to the income statement as the related expenditure is incurred.
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the statement of financial position date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to the income statement.
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery 25% & 12.5% Straight Line
Computer Equipment 33.33% Straight Line
Defined contribution pension obligation
A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.
Financial instruments
A financial instrument is a contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.

When a financial asset or financial liability is recognised initially, the entity shall measure it at the transaction price unless the arrangement constitutes, in effect, a financing transaction. An arrangement constitutes a financing transaction if payment is deferred beyond normal business terms or is financed at a rate of interest that is not a market rate.

At the end of each reporting period, an entity shall measure all financial instruments which constitute a financing arrangement at fair value and recognise changes in fair value in profit or loss.
2.

Average number of employees

Average number of employees during the year was 3 (2024 : 3).
3.

Tangible fixed assets

Cost or valuation Plant and Machinery   Computer Equipment   Total
  £   £   £
At 01 October 2024 17,659    6,821    24,480 
Additions 59,525    3,594    63,119 
Disposals (1,820)     (1,820)
At 30 September 2025 75,364    10,415    85,779 
Depreciation
At 01 October 2024 1,083    2,085    3,168 
Charge for year 6,004    3,041    9,045 
On disposals (350)     (350)
At 30 September 2025 6,737    5,126    11,863 
Net book values
Closing balance as at 30 September 2025 68,627    5,289    73,916 
Opening balance as at 01 October 2024 16,576    4,736    21,312 


4.

Debtors: amounts falling due within one year

2025
£
  2024
£
Trade Debtors 13,308   
Prepayments & Accrued Income 8,204    4,948 
Other Debtors 548    548 
VAT 4,063    3,029 
26,123    8,525 

5.

Creditors: amount falling due within one year

2025
£
  2024
£
Trade Creditors 59,683    16,115 
Corporation Tax 2,471    882 
PAYE & Social Security 2,009    2,589 
Pension Payable 562    551 
Accrued Expenses 1,565    1,490 
Deferred Grants 178,369    111,494 
Credit Card 2,968    1,662 
Directors' Current Accounts 1,524    14,424 
249,151    149,207 

6.

Director’s loan

Ms C B Pratt

Particulars   2025
£
  2024
£
Opening Balance (14,424) (13,870)
Advances to director 14,424 
Repayments by director (1,524) (554)
Closing Balance (1,524) (14,424)

The loan is interest free with no fixed date of repayment.
7.

Company Limited by Guarantee

The company is limited by guarantee and therefore has no shares. The company is not established or conducted for private gain: any surplus or assets are used to further the objects.
3